Great new, BUT
Lately, headlines claiming that “pancreatic cancer has been completely eliminated in mice” are circulating widely.
The core information is true; the conclusion drawn from it is wrong.
Mariano Barbacid and his team demonstrated a triple-targeted treatment combination that very strongly suppresses pancreatic cancer in mouse models. In some mice, tumors completely disappeared and no recurrence was observed.
But let’s pause.
This is a preclinical study. Meaning: – It has not been tested in humans
– Efficacy and safety are unknown
– It does not represent a clinical treatment
Seeing “complete responses” in mouse models is not new in pancreatic cancer research. The real challenge has always been translating these results to humans. Tumor biology and the microenvironment often break the effect when moving from mice to patients.
Why does this still matter?
Because simultaneously targeting KRAS, EGFR, and STAT3-related resistance pathways shows real biological relevance. That is a valid scientific signal.
Let’s be clear: “A cure has been found” — false
“Patients will soon be cured” — false
“A promising laboratory signal worth testing in humans” — true
@JeepMx Ni la compren, pésimo servicio post venta
La mía le dejo de funcionar el aire acondicionado (2024) y tardarán 2 meses en traer la refacciones. Se la pasa en la agencia
General #surgery video: Laparoscopic total gastrectomy using indocyanine green (ICG) for lymph node mapping (LNM) in gastric cancer Watch here: https://t.co/ZZNGKR9QhJ
Learn how indocyanine green (ICG) enhances lymph node mapping in laparoscopic gastrectomy, improving precision.
Life lessons from @rogerfederer (must watch)
1 Effortless is a myth
2 Belief in yourself has to be earned
3 Grit > Gift
4 Discipline is talent
5 Trust and loving the process is talent
6 You can do your best and still lose
7 Life is bigger than the court
[ARTÍCULO DE LA SEMANA] 📣
By @saludempatica
Thyroid Cancer: A Review
Revisión que resume la evidencia actual sobre la fisiopatología, el diagnóstico y el tratamiento del cáncer de tiroides en etapa temprana y avanzada
doi:10.1001/jama.2023.26348
#surgery#head#neck#Medical